Search Results

The Signia™ Stapler, when used with Endo GIA™ single-use reloads, Endo GIAM single-use reloads with Tri-Staple™ Technology. Tri-Staple™ 2.0 single-use reloads and Sigma™ loading with Tri-Staple™ 2.0 single-use cartidges. has applications in abdominal, gynecological, pediatic, and thoracic surgery for resection, and creation of anastomosis. It may be used for transection of liver substance, hepatic vasculature, and biliary stuctures and for transection and resection of the pancreas.

The Signia™ Stapler, when used with Endo GIA™ curved tip single use reloads or Tri-Staple™ 2.0 curved tip single-use reloads, can be used to blunt dissect or separate target tissue from other certain tissue.

The Signia TM Stabler, when used with single use Radial Reloads with Tri-Staple™ Technology, has applications in open or minimally invasive general abdominal, gynecologic, pediatric and thoracic surgery for resection and transection of tissue and creation of anastomosis, as well as application deep in the pelvis, i.e., low anterior resection. It may be used for transection of liver substance, hepatic vasculature and biliary structures and for transection and resection of the pancreas.

The Signia™ Stapler, when used with Endo GIA™ single use reinforced reloads with Tri-Staple™ Technology preloaded with polyglycolic acid staple line reinforcement or Tri Staple™ 2.0 single use reinforced reloads preloaded with polyglycolic acid staple line reinforcement, has applications in abdominal, gynecologic, pediatric and thoracic surgery for resection, transection of tissue and creation of anastomosis. It may be used for transection of liver substance, hepatic vasculature and biliary structures, and for transection and resection of the pancreas.

The Signia™ Stapler is a battery powered microprocessor controlled surgical stapler that provides pushbutton powered maneuverability and firing of compatible Covidien stapling reloads. The Signia™ Stapler when used with a compatible reload is a surgical device for stapling and cutting tissues. The Signia™ Stapler is intended to be used by medical professionals qualified in the transportation, preparation, cleaning, sterilization, and use of surgical devices. All of which stay unchanged when compared to the predicate device.

The Signia™ Stapler is composed of the Signia™ Power Handle, Signia™ Power Shell, and Signia™ Linear Adapter. System accessories include the Signia™ Reusable Insertion Guide, Signia™ Manual Retraction Tool, Signia™ Single Bay Charger, Signia™ Sterilization Tray (optional), and Signia™ Four-Bay Smart Charger (optional).

The design modification is to introduce the new software version for the Signia™ Power Handle. The new software will extend the real time force gauge display on the Signia™ Power Handle for the non-intelligent reloads that are already in the market without an ID chip. Currently, the force gauge is displayed only when an intelligent reload with an ID chip is attached to the Signia™ Stapler. By installing the new software, the force gauge will be displayed consistently for all compatible Covidien reloads. This is a user interface/display change but does not impact how the handle operates.

The FDA 510(k) summary for the Signia™ Stapler with new software (K201672) does not include specific acceptance criteria or an explicit study proving the device meets those criteria in the way typically found for diagnostic algorithms. This submission is for a modification to an existing surgical stapler, primarily focusing on a software update that affects the user interface and display of a force gauge. Therefore, the details requested in your prompt (e.g., sample size for test sets, ground truth establishment, MRMC studies) are not directly applicable or present in this document.

However, I can extract the relevant information regarding the software change and the types of studies performed to demonstrate substantial equivalence.

Here's a breakdown of the available information in the context of your request:

1. Table of Acceptance Criteria and Reported Device Performance

The document does not explicitly state quantitative acceptance criteria for the software change in terms of metrics like sensitivity, specificity, or accuracy, which are common for diagnostic AI. Instead, the "acceptance criteria" are implied by the demonstration of substantial equivalence through verification and performance testing that the software change does not negatively impact safety or effectiveness.

2. Sample Size Used for the Test Set and Data Provenance

The document states: "Non-clinical performance data such as software verification and performance testing have demonstrated substantial equivalence to the predicate device."

• Test set sample size: Not specified. The testing would likely involve internal software verification and validation (V&V) tests, which might use various simulated scenarios or bench test results rather than a "test set" in the sense of clinical data.
• Data provenance: Not explicitly stated as country of origin. Given it's "non-clinical performance data" and "software verification and performance testing," it would be internal engineering and quality testing rather than retrospective or prospective clinical data.

3. Number of Experts Used to Establish Ground Truth and Qualifications

• Number of experts: Not applicable/not specified. For software verification and performance testing of a device's functional display, the "ground truth" is typically defined by the device's design specifications and expected behavior, verified by engineers.
• Qualifications of experts: Not applicable/not specified.

4. Adjudication Method for the Test Set

• Adjudication method: Not applicable/not specified. This type of software change would not typically involve expert adjudication in the way clinical diagnostic studies do.

5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study

• MRMC study: No. The document explicitly states: "Clinical performance data – No clinical study has been performed." This is not a diagnostic AI device requiring comparison with human readers.

6. Standalone Performance (Algorithm Only Without Human-in-the-Loop Performance)

• This concept is not directly applicable in the terms of a standalone diagnostic algorithm. The software update is for a component of a surgical stapler, which is always used by a human surgeon. The "performance" being evaluated is whether the software correctly displays the force gauge for non-intelligent reloads without affecting the device's core functionality or safety. This is a functional and safety assessment within the device, not a standalone diagnostic output.

7. Type of Ground Truth Used

• Type of ground truth: The "ground truth" for this software modification would be the design specifications and expected functional behavior of the device's display and operation. The verification and performance testing would confirm that the software change aligns with these predefined specifications and does not introduce new safety or effectiveness concerns.

8. Sample Size for the Training Set

• Training set sample size: Not applicable/not specified. As this is a software update for a medical device's user interface, it is likely developed through traditional software engineering processes, not machine learning that requires a "training set" in the AI sense.

9. How the Ground Truth for the Training Set was Established

• Ground truth for training set: Not applicable. (See point 8).

In summary: The FDA 510(k) for the Signia™ Stapler with new software focuses on demonstrating that a software update to extend display functionality does not alter the device's intended use, indications, or fundamental safety and effectiveness profile. The "study" referenced is non-clinical performance and software verification testing, which confirms adherence to design specifications rather than clinical outcomes or diagnostic accuracy comparisons.

Ask a specific question about this device

The Signia™ stapler, when used with the Signia™ circular adapters and Tri-Staple™ 2.0 circular single use reloads, has applications throughout the alimentary tract for the creation of end-to-end, end-to-side, and side-to-side anastomoses in both open and laparoscopic surgeries.

The Signia™ stapler, when used with the Signia™ circular adapters and Tri-Staple™ 2.0 circular single use reloads, is a battery powered microprocessor controlled stapler that provides push-button powered maneuverability and firing of compatible reloads. The Signia™ Stapler is intended to be used by medical professionals qualified in the transportation, cleaning, sterilization, and use of surgical devices. The Signia™ stapler is intended for use in a sterile operating room environment in surgical procedures where surgical stapling is indicated.

The Signia™ circular adapters are reusable instruments that connect with the assembled Signia™ Power Handle and the Signia™ Power Shell to make up the Signia™ stapler. The circular adapters are composed of motor-mating connectors, sensor gauge, and device communications interfaces to provide functionality and communications between compatible reloads and the Signia™ Power Handle. The user can manually rotate the handle in 0, 90, 180 degrees to position the device if required, and the user can fire within these locked and rotated positions. The circular adapters are available in two shaft lengths, standard and extra-long, and both sizes are compatible with the new Tri-Staple™ 2.0 circular reloads.

The Tri-Staple™ 2.0 circular reloads place a circular triple staggered row of titanium staples. After staple formation, the knife blade resects the excess tissue, creating a circular anastomosis such as end-to-end, end-to-side, or side-to-side anastomosis as the user sees fit. The new circular reloads will be offered for a medium/thick tissue thickness range, which is identified by the purple staple guide. The circular reloads deploy three height-progressive rows of 3.0 mm. 3.5 mm and 4.0 mm titanium staples. The Tri-Stable™ 2.0 technology incorporated in the reloads is essentially the same as the legally-marketed predicate K172361 in terms of reload design. The circular reloads are provided sterile for single use, and available in five lumen sizes: 21, 25, 28, 31, and 33 mm. The Tilt-Top™ anvil is available with all circular reloads.

To create a circular anastomosis, the Signia™ Stapler consists of the Signia™ Power Handle, Signia™ Power Shell, Signia™ Circular Adapter, and Tri-Staple™ 2.0 circular reload. The existing system accessories such as Signia™ Reusable Insertion Guide, Signia™ Manual Retraction Tool, Signia™ Single Bay Charger, Signia™ Sterilization Tray (optional), and Signia™ Four-Bay Smart Charger (optional) can be also used.

The provided document is a 510(k) Summary for a medical device (Signia Circular Adapters and Tri-Staple 2.0 Circular Reloads for use with the Signia Stapler). It describes the device, its intended use, and substantial equivalence to a predicate device, supported by non-clinical studies. However, it does not contain a machine learning/AI component or corresponding studies.

Therefore, I cannot extract the information required in the prompt regarding acceptance criteria and studies that prove a device meets those criteria through AI/ML performance. The document focuses on showing substantial equivalence based on engineering and performance tests relevant to a traditional medical device, not an AI-powered one.

If there were a section describing an AI/ML component, I would look for information such as:

• Acceptance Criteria Table: A table outlining specific performance metrics (e.g., sensitivity, specificity, accuracy, F1-score) and their target values.
• Reported Device Performance: The actual measured performance of the AI device against those metrics.
• Sample Size and Data Provenance: Details about the dataset used for testing, including its size, origin (e.g., country, institution), and whether it was prospective or retrospective.
• Ground Truth Experts: The number and qualifications of experts involved in establishing the ground truth labels for the test data.
• Adjudication Method: How disagreements among experts were resolved to establish the final ground truth.
• MRMC Study: Information on multi-reader multi-case studies, including the effect size (improvement in human performance with AI assistance).
• Standalone Performance: Details of any study evaluating the algorithm's performance without human intervention.
• Type of Ground Truth: The method used to determine the true labels (e.g., pathology, long-term follow-up, expert consensus).
• Training Set Sample Size: The amount of data used to train the AI model.
• Training Set Ground Truth: How the ground truth for the training data was established.

Since this information is not present in the provided document, I cannot fulfill the request as it relates to AI/ML device performance.

Ask a specific question about this device

The Signia™ Stapler, when used with Endo GIA™ single-use reloads, Endo GIA™ single-use reloads with Tri-Staple™ Technology, Tri-Staple™ 2.0 single use reloads and Signia™ loading units with Tri-Staple™ 2.0 single-use cartridges, has applications in abdominal, gynecological, pediatric, and thoracic surgery for resection, and creation of anastomosis. It may be used for transection of liver substance, hepatic vasculature, and biliary structures and for transection and resection of the pancreas.

The Signia™ Stapler, when used with Endo GIA™ curved tip single use reloads or Tri-Staple™ 2.0 curved tip single-use reloads, can be used to blunt dissect or separate target tissue from other certain tissue.

The Signia™ Stapler, when used with Endo GIA™ single use Radial Reloads with Tri-Staple™ Technology, has applications in open or minimally invasive general abdominal, gynecologic, pediatric and thoracic surgery for resection and transection of tissue and creation of anastomosis, as well as application deep in the pelvis, i.e., low anterior resection. It may be used for transection of liver substance, hepatic vasculature and biliary structures and for transection and resection of the pancreas.

The Signia™ Stapler, when used with Endo GIA™ single use reinforced reloads with Tri-Staple™ Technology preloaded with polyglycolic acid staple line reinforcement or Tri Staple™ 2.0 single use reinforced reloaded with polyglycolic acid staple line reinforcement, has applications in abdominal, gynecologic, pediatric and thoracic surgery for resection, transection of tissue and creation of anastomosis. It may be used for transection of liver substance, hepatic vasculature and biliary structures, and for transection and resection of the pancreas.

The Signia™ Stapler is a battery powered microprocessor controlled surgical stapler that provides push-button powered maneuverability and firing of compatible Covidien stapling reloads. The Signia™ Stapler is compatible with Endo GJA™ single-use reloads, Endo GIA™ single-use reloads with Tri-Staple™ Technology, Tri-Staple™ 2.0 single use reloads, and Signia™ loading units with Tri-Staple™ Otape - roomnology, The Signia™ Stapler when used with the abovementioned family of Endo GIA™ reloads is a surgical device for stapling and cutting tissues. The Signia™ Stapler is intended to be used by medical professionals qualified in the transportation, preparation, cleaning, sterilization, and use of surgical devices. All of which stay unchanged when compared to the predicate device.

The Signia™ Stapler is composed of the Signia™ Power Handle, Signia™ Power Shell, and Signia™ The Signia - System accessories include the Signia™ Reusable Insertion Guide, Signia™ Manual Retraction Tool, Signia™ Single Bay Charger, Signia™ Sterilization Tray, and this submission introduces a new accessory, Signia™ Four-Bay Smart Charger. The Smart Charger's primary purpose introduces a new as the Signia Single-Bay Charger in K160176, but the difference is that Smart Charger offers enhanced features such as four charging stations, a touch-screen LCD display, and data management interface in order to improve user convenience.

This document describes a 510(k) premarket notification for a medical device: the Signia™ Four-Bay Smart Charger, an accessory to the Signia™ Stapler. The submission aims to demonstrate substantial equivalence to a legally marketed predicate device.

Crucially, this document explicitly states that no clinical study has been performed to demonstrate performance of the device itself. The substantial equivalence is based on non-clinical studies. Therefore, it is not possible to provide information on acceptance criteria and a study proving device performance as requested, because such a study was explicitly stated as not performed.

The document focuses on the safety and technological characteristics of the charger accessory and its equivalence to a prior charger, not on clinical performance of the stapler system which it charges.

Here's why the requested information cannot be extracted from the provided text:

• No Clinical Performance Data: The statement "Clinical performance data -- No clinical study has been performed. The substantial equivalence has been demonstrated by non-clinical studies" directly contradicts the premise of the questions regarding device performance, acceptance criteria, and study details.
• Focus on Charger, Not Stapler: The device under review (Signia™ Four-Bay Smart Charger) is an accessory to the Signia™ Stapler. The 510(k) submission focuses on the charger's safety and features (e.g., four charging stations, touchscreen, data management) as substantially equivalent to an existing charger, not on the clinical performance of the stapler itself in surgical procedures.
• "Acceptance Criteria" for a Charger: While there are non-clinical acceptance criteria mentioned for the charger (Software V&V, Electrical Safety, EMC Testing, Usability Evaluation), these are engineering and regulatory compliance criteria, not clinical performance metrics tied to patient outcomes or diagnostic accuracy. They do not involve "device performance" in the sense of a medical outcome.

Therefore, I cannot fulfill your request for specific details on "acceptance criteria and the study that proves the device meets the acceptance criteria" in the context of clinical performance, as the document clearly states no such clinical study was done for this submission.

The information provided is specific to the regulatory approval process for an accessory and its non-clinical testing.

Ask a specific question about this device

The Signia™ stapler, when used with Endo GIA™ single-use reloads, Endo GIA™ single-use reloads with Tri-Staple™ Technology, Tri-Staple™ 2.0 single-use reloads and Signia™ loading units with Tri-Staple™ 2.0 single-use cartridges, has applications in abdominal, gynecological, pediatric, and thoracic surgery for resection, transection, and creation of anastomosis. It may be used for transection and resection of liver substance, hepatic vasculature, and biliary structures and for transection and resection of the pancreas.

The Signia™ stapler, when used with Endo GIA™ curved tip single use reloads or Tri-Staple™ 2.0 curved tip single-use reloads, can be used to blunt dissect or separate target tissue from other certain tissue.

The Signia™ stapler, when used with Endo GIA™ single use Radial Reloads with Tri-Staple™ Technology, has applications in open or minimally invasive general abdominal, gynecologic, pediatric and thoracic surgery for resection and transection of tissue and creation of anastomosis, as well as application deep in the pelvis, i.e., low anterior resection. It may be used for transection and resection of liver substance, hepatic vasculature and biliary structures and for transection and resection of the pancreas.

The Signia™ stapler. when used with Endo GIA™ single use reinforced reloads with Tri-Staple™ Technology preloaded with polyglycolic acid staple line reinforcement or Tri-Staple™ 2.0 single use reinforced reloads preloaded with polyglycolic acid staple line reinforcement, has applications in abdominal, gynecologic, pediatric and thoracic surgery for resection, transection of tissue and creation of anastomosis. It may be used for transection and resection of liver substance, hepatic vasculature and biliary structures, and for transection and resection of the pancreas.

The Signia™ Stapler is a battery powered microprocessor controlled surgical stapler that provides push-button powered maneuverability and firing of compatible Covidien stapling reloads. The Signia™ Stapler is composed of the Signia™ Power Handle, Signia™ Power Shell, and Signia™ Linear Adapter. System accessories include the Signia™ Reusable Insertion Guide, Signia™ Manual Retraction Tool, and Signia™ Single Bay Charger.

The User controls the Signia™ Stapler via button presses on the Handle and receives feedback status and other information from the Handle via its OLED Display, LED indicator and audible annunciator. Pushbutton / Toggle switches on the Handle are provided for:

• Stapling activation: Advancing the Firing Rod / Clamping / Unclamping .
• Left and Right Articulation .
• Clockwise and Counter Clockwise Rotation .

When the appropriate buttons are pressed, the Signia™ Stapler software initiates stapling (firing), articulation or rotation operation by turning on the appropriate motor. The motors have built-in encoders which provide shaft position information. The software controls motor speed and position using encoder pulses. Since it is possible to press multiple keys simultaneously, software must be able to process them and take appropriate actions.

The Signia™ Stapier is compatible with Endo GIA™ single-use reloads, Endo GIA™ single-use reloads with Tri-Staple™ Technology, Tri-Staple™ 2.0 single use reloads, and Signia™ loading units with Tri-Staple™ 2.0 single-use cartridges.

The Signia™ Stapler when used with the abovementioned family of Endo GIA™ reloads is a surgical device for stapling and cutting tissues. The Signia™ Stapler is intended to be used by medical professionals qualified in the transportation, cleaning, sterilization, and use of surgical devices.

This document is a 510(k) premarket notification from the FDA regarding the Covidien Signia™ Stapler, a surgical stapler. It describes the device, its intended use, and the tests performed to demonstrate its substantial equivalence to a predicate device.

There is no information in the provided document about AI implementation, acceptance criteria for AI performance, clinical study results proving device meets acceptance criteria, sample sizes for test/training sets, data provenance, expert qualifications, ground truth establishment, MRMC studies, or standalone algorithm performance.

The document does list various tests performed (Lifecycle Reliability, Cleaning Validation, Aseptic Barrier, Functional Performance, Usability, Biocompatibility, Electrical Safety, EMC/EMI) to show that the Signia™ Stapler is substantially equivalent to a predicate device (iDrive™ Ultra Powered Handle with Endo GIA™ Adapter) based on its technological and performance characteristics, and not based on AI performance or clinical performance data.

Therefore, I cannot provide the requested information regarding acceptance criteria and a study proving AI device performance, as the document pertains to a traditional medical device (stapler) and its substantial equivalence without mention of AI.

To directly answer your specific points based only on the provided text, many are "Not Applicable" or "Not Provided":

1. A table of acceptance criteria and the reported device performance:

   • Not Provided. The document states that "Qualitative and quantitative data were obtained and used to compare the Signia™ Stapler to the predicate iDrive Ultra™ Powered Handle with Endo GIA™ Adapter," and that "The design differences were found to not affect safety or performance through applicable design verification activities that showed conformance to applicable technical design specifications and performance requirements, applicable medical device performance standards, and other nonclinical testing." However, specific acceptance criteria for these tests or the quantitative performance results are not detailed in this summary. It's focused on "substantial equivalence" to a predicate device without specific performance metrics listed in this public summary.

2. Sample sizes used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective):

   • Not Provided. The document mentions "Functional Performance Test Bench and Animal" studies but does not specify sample sizes or data provenance (country, retrospective/prospective nature).

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience):

   • Not Applicable. This is a hardware surgical device, not an AI or diagnostic device that requires expert-established ground truth on a test set in the manner described for AI. The "ground truth" would be the engineering specifications and performance capabilities of the device itself and its predicate.

4. Adjudication method (e.g. 2+1, 3+1, none) for the test set:

   • Not Applicable. See point 3.

5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:

   • Not Applicable. This is not an AI device. The document explicitly states: "This premarket submission did not rely on the assessment of clinical performance data to demonstrate substantial equivalence."

6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done:

   • Not Applicable. This is not an AI algorithm.

7. The type of ground truth used (expert consensus, pathology, outcomes data, etc):

   • Not Applicable in the context of AI. For a surgical stapler, the ground truth relates to its mechanical and functional performance, safety standards, and equivalence to a legally marketed predicate device. This would typically involve engineering specifications, material properties, mechanical testing results (e.g., staple formation, tissue compression, firing force), and possibly animal studies for functional performance.

8. The sample size for the training set:

   • Not Applicable. No AI training set is mentioned or implied.

9. How the ground truth for the training set was established:

   • Not Applicable. No AI training set is mentioned or implied.

In summary, the provided FDA document is a regulatory letter concerning the substantial equivalence of a physical surgical stapler, not an AI-powered medical device. Therefore, the questions related to AI performance, test sets, ground truth establishment by experts, and MRMC studies are not addressed by this document.

Ask a specific question about this device